Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 52 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

19%

10 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

17 recruiting

Enrollment Performance

Analytics

N/A
20(51.3%)
Phase 2
9(23.1%)
Phase 3
9(23.1%)
Phase 4
1(2.6%)
39Total
N/A(20)
Phase 2(9)
Phase 3(9)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials
NCT07074444Not ApplicableRecruiting

Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel

Role: collaborator

NCT06763289Active Not Recruiting

Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection

Role: collaborator

NCT07764887Not ApplicableNot Yet Recruiting

Impacted Tooth Management and Osteoradionecrosis Risk in NPC

Role: collaborator

NCT07712848Phase 3Recruiting

DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML

Role: collaborator

NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07176754Not ApplicableActive Not Recruiting

TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Role: collaborator

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT06274411Not ApplicableRecruiting

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

Role: collaborator

NCT07077343Not ApplicableRecruiting

AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH

Role: collaborator

NCT06429527Not ApplicableEnrolling By Invitation

Evaluating App-Based Vision Testing (WHOeyes) Combined With the Questionnaire as a Substitute for One-Week Postoperative In-Clinic Follow-Up in Age-Related Cataract Patients: A Multi-center Randomized Controlled Trial

Role: collaborator

NCT05787522Completed

Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk

Role: collaborator

NCT07157631Not ApplicableRecruiting

Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial

Role: collaborator

NCT07145814Not ApplicableCompleted

Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery

Role: lead

NCT06228079Phase 3Recruiting

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

Role: collaborator

NCT06603948Not ApplicableCompleted

Spectral Focused Imaging Versus White Light Imaging in Colorectal Adenoma Detection

Role: collaborator

NCT07012941Not ApplicableNot Yet Recruiting

Super-Pulsed Thulium Fiber Laser Versus Holmium:YAG Laser in Retrograde Intrarenal Surgery for Upper Ureteral and Renal Stones

Role: collaborator

NCT06235203Phase 3Recruiting

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Role: collaborator

NCT06810791Phase 3Recruiting

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Role: collaborator

NCT06481410Not ApplicableRecruiting

Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock

Role: collaborator